RORγt agonist 4
RORγt agonist 4 (compound 14) is a potent and selective agonist of RORγt. RORγt agonist 4 significantly enhances metabolic stability. RORγt agonist 4 improves the situation of tumor models of mouse B16F10 melanoma and LLC lung adenocarcinoma[1].
Product Specifications
CAS Number
2241769-59-3
UNSPSC
12352005
Target
ROR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rorγt-agonist-4.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C(OC(C)C)C=CC(C2=C(C=C(NC(CC3=CC=C(S(=O)(CC)=O)C=C3)=O)C=C2Cl)Cl)=C1
Molecular Formula
C26H24Cl2N2O4S
Molecular Weight
531.45
References & Citations
[1]Lu L, et al. Discovery of Biaryl Amide Derivatives as Potent, Selective, and Orally Bioavailable RORγt Agonists for Cancer Immunotherapy. J Med Chem. 2023 Nov 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61229R-HRP-01 20 µL
GOLPH2 Recombinant Antibody, HRP Conjugated
Sign In for Pricing
View Details bsm-61229R-HRP-02 100 µL
GOLPH2 Recombinant Antibody, HRP Conjugated
Sign In for Pricing
View Details 